title: Hepatitis C recurrence: influence of serum cholesterol levels and liver steatosis on antiviral therapy.
authors.forename: Gianni
authors.initials: G
authors.lastname: Testino
authors.forename: Paolo
authors.initials: P
authors.lastname: Borro
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood*; D005234:Fatty Liver / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D016031:Liver Transplantation / Q000502:physiology; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014280:Triglycerides; D011092:Polyethylene Glycols; D012254:Ribavirin; D002784:Cholesterol; C417083:peginterferon alfa-2b